क्यूआर कोड

Beyond valganciclovir: A meta-analysis of letermovir’s safety and efficacy in cytomegalovirus prophylaxis after solid organ transplantation

Abstract Background Cytomegalovirus (CMV) remains a major infectious cause of morbidity and graft dysfunction after solid organ transplantation (SOT). Valganciclovir (VGC) is effective for CMV prophylaxis but limited by myelotoxicity. Letermovir (LTV), a CMV terminase complex inhibitor, offers a non...

पूर्ण विवरण

में बचाया:
मुख्य लेखकों: Muhammad Usman, Zhihan Yuan, Hao Yu, Xutao Chen, Zhuang Tang, Cheng Liu, Zhouhang Li, Wang He, Kewei Xu
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: BMC 2026-03-01
श्रृंखला:BMC Infectious Diseases
विषय:
Letermovir
Valganciclovir
Cytomegalovirus
Solid organ transplantation
Prophylaxis
ऑनलाइन पहुंच:https://doi.org/10.1186/s12879-026-13022-1
टैग: टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन